Results 111 to 120 of about 97,768,097 (202)

2-Methoxyestradiol-bis-sulphamate : a promising anticancer agent in an esophageal carcinoma (SNO) cell line [PDF]

, 2013
2-Methoxyestradiol-bis-sulphamate (2-MeOE2bisMATE) is a bis-sulphamoylated analogue of a biological estradiol metabolite, 2-methoxyestradiol (2ME2) with potential as an anticancer drug.
Marais, Sumari, Joubert, Annie M., Mqoco, T.V. (Thandi Vuyelwa)   +2 more
core  

Influence of estradiol analogue on cell growth, morphology and death in esophageal carcinoma cells [PDF]

, 2010
2-Methoxyestradiol-bis-sulphamate is a bis-sulphamoylated derivative of the naturally occurring 17-beta-estradiol metabolite namely 2-methoxyestradiol.
Marais, Sumari, Joubert, Annie M., Mqoco, T.V. (Thandi Vuyelwa)   +2 more
core  

Protective Effects of 2-Methoxyestradiol on Acute Isoproterenol-Induced Cardiac Injury in Rats. [PDF]

Saudi Pharm J, 2023
Hareeri RH, Alam AM, Bagher AM, Alamoudi AJ, Aldurdunji MM, Shaik RA, Eid BG, Ashour OM.   +7 more
europepmc   +1 more source

Genotoxic Damage to Glioblastoma Cells Treated with 6 MV X-Radiation in The Presence or Absence of Methoxy Estradiol, IUDR or Topotecan

Cell Journal, 2015
Objective: To explore the cumulative genotoxic damage to glioblastoma (GBM) cells, grown as multicellular spheroids, following exposure to 6 MV X-rays (2 Gy, 22 Gy) with or without, 2- methoxy estradiol (2ME2), iododeoxyuridine (IUDR) or topotecan (TPT)
Nazila Eyvazzadeh, Ali Neshasteh-Riz, Seyed Rabee Mahdavi, Afshin Mohsenifar   +3 more
doaj  

Effect of 2-methoxyestradiol treatment on early- and late-stage breast cancer progression in a mouse model. [PDF]

Cell Biochem Funct, 2023
Peta KT, Durandt C, van Heerden MB, Joubert AM, Pepper MS, Ambele MA.   +5 more
europepmc   +1 more source

Mechanisms for 2‐methoxyestradiol‐induced apoptosis of prostate cancer cells

, 2002
Prostate and breast carcinomas are sex hormone-related carcinomas, which are known to be associated with an over-expression of the proto-oncogene Bcl-2.
Shizhong Bu, Nils-Erik Heldin, Landström, Maréne,, Blaukat, Andree,, Bu, Shizhong,, Xin Fu, Andree Blaukat, Heldin, Nils-Erik,, Maréne Landström, Fu, Xin,   +9 more
core   +1 more source

PEGylated Polymeric Nanoparticles Loaded with 2-Methoxyestradiol for the Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model. [PDF]

J Pharm Sci, 2023
Enazy SA, Kirschen GW, Vincent K, Yang J, Saada J, Shah M, Oberhauser AF, Bujalowski PJ, Motamedi M, Salama SA, Kilic G, Rytting E, Borahay MA.   +12 more
europepmc   +1 more source

2-Methoxyestradiol [PDF]

, 2020
openaire   +1 more source

Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer

, 2013
Jinjin Shi, Zhenzhen Wang, Lei Wang, Honghong Wang, Lulu Li, Xiaoyuan Yu, Jing Zhang, Rou Ma, Zhenzhong ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, People's Republic of ChinaAbstract: Fullerene (C60) has shown great ...
Ma R, Zhang J, Zhang Z, Wang H, Shi J, Wang Z, Li L, Yu X, Wang L   +8 more
core  

研究2-甲氧基雌激二醇單獨使用或是合併不同種類化療藥物對於抑制人類子宮內膜癌細胞的作用

, 2011
Objective: 2-methoxyestradiol (2-ME), an endogenous estradiol metabolite, has potent antiproliferative effects on cancer cells. However, its usefulness for treating endometrial cancer has not yet been fully explored .
陳啟豪;李文瑞;張廷禎;陳瑞堅;簡靜香;周松男, CHEN, CHI-HAU;LEE, WEN-JUI;CHANG, TING-CHEN;CHEN, RUEY-JIEN;CHIEN, CHIN-HSIANG;CHOW, SONG-NAN   +1 more
core